Integrative Genomic-Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis
Clozapine (CLZ) is the only antipsychotic drug that has been proven to be effective in patients with refractory psychosis, but it has also been proposed as an effective mood stabilizer; however, the complex mechanisms of action of CLZ are not yet fully known. To find predictors of CLZ-associated phe...
Saved in:
Main Authors: | Yerye Gibrán Mayén-Lobo (Author), José Jaime Martínez-Magaña (Author), Blanca Estela Pérez-Aldana (Author), Alberto Ortega-Vázquez (Author), Alma Delia Genis-Mendoza (Author), David José Dávila-Ortiz de Montellano (Author), Ernesto Soto-Reyes (Author), Humberto Nicolini (Author), Marisol López-López (Author), Nancy Monroy-Jaramillo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021) -
Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum Psychosis
by: Teodorescu A, et al.
Published: (2021) -
Epigenetics and Epigenomics
Published: (2014) -
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidence
by: Ebenezer Oloyede, et al.
Published: (2022) -
Role of DNA Methyltransferases in the Epigenome
by: Jeltsch, Albert
Published: (2020)